Andrew Brosnan is a senior analyst in the Ovum Health Sciences team. Andrew’s research focuses on the use of technology in the pharmaceutical and biotechnology markets.
Andrew has considerable experience working with life sciences applications. He has held a variety of positions and led several divisional and enterprise-wide IT projects. His experience includes working closely with scientific stakeholders as well as bench researchers, giving him a unique perspective on the technology needs and experiences of end users in a laboratory setting.
Prior to joining Ovum, Andrew was a project leader and application analyst in Merck and Co.’s drug discovery IT division. He was a subject matter expert for several applications within the drug discovery portfolio including data mining, data archival, and lab automation applications. He also started his own firm in which he provided IT consulting services to the pharmaceutical sector.
Andrew has additional experience in the financial sector in both a financial and IT capacity, having worked as a bank examiner for the US Treasury Department and holding several supervisory positions within financial IT departments.
Andrew holds a BA from Boston University and is currently enrolled in Warwick University’s Executive MBA program.